Skip to main content

Table 2 Placental malaria distribution by maternal factors

From: Age-modified factors associated with placental malaria in rural Burkina Faso

Maternal Factors

N

Placental malaria

  

No

Past

Chronic

Acute

Baseline

     

  Age (years)

     

    < 30

588

50 (8.50)

381 (64.8)

152 (25.9)

5 (0.9)

    ≥ 30

157

48 (30.6)

85 (54.1)

18 (11.5)

6 (3.8)

  Gravidity

     

    ≤ 2

355

12 (3.4)

231 (65.1)

110 (31.0)

2 (0.6)

    > 2

390

86 (22.1)

235 (60.3)

60 (15.4)

9 (2.3)

  Bednet use the previous night

     

    No

370

46 (12.4)

215 (58.1)

105 (28.4)

4 (1.1)

    Yes

375

52 (13.9)

251 (66.9)

65 (17.3)

7 (1.9)

  Received IPTp before study start

     

    Yes

97

8 (8.2)

68 (70.1)

17 (17.5)

4 (4.1)

    No

648

90 (13.9)

398 (61.4)

153 (23.6)

7 (1.1)

  Anemia at study start(Hb <11g/dl)

     

    Yes

553

61 (11.0)

349 (63.1)

137 (24.8)

6 (1.1)

    No

192

37 (19.3)

117 (60.9)

33 (17.2)

5 (2.6)

  Underweight at study start(BMI <18.5kg/m2)

     

    Yes

46

3 (6.5)

30 (65.2)

13 (28.3)

0 (0.0)

    No

699

95 (13.6)

436 (62.4)

157 (22.5)

11 (1.6)

  Symptomatic malaria at study start*

     

    Yes

308

24 (7.8)

191 (62.0)

91 (29.5)

2 (0.6)

    No

436

74 (17.0)

275 (63.1)

78 (17.9)

9 (2.1)

  Treatment at random*

     

    AL

242

29 (12.0)

159 (65.7)

50 (20.7)

4 (1.7)

    ASAQ

255

31 (12.2)

161 (63.1)

61 (23.9)

2 (0.8)

    MQAS

247

38 (15.4)

146 (59.1)

58 (23.5)

5 (2.0)

Follow-up

     

  Recurrent malaria during follow-up*

     

    Yes

289

19 (6.6)

172 (59.5)

94 (32.5)

4 (1.4)

    No

454

79 (17.4)

293 (64.5)

75 (16.5)

7 (1.5)

  Season at delivery*

     

    Rainy

447

35 (7.8)

259 (57.9)

144 (32.2)

9 (2.0)

    Dry

297

63 (21.2)

206 (69.4)

26 (8.8)

2 (0.7)

  1. Numbers are frequencies (percentages)
  2. IPTp intermittent preventive treatment of malaria during pregnancy with sulfadoxine-pyrimethamine, AL artemether-lumefantrine, ASAQ artesunate-amodiaquine, MQAS mefloquine-artesunate, Hb hemoglobin, BMI body mass index
  3. *Missing data for one woman for symptomatic malaria, treatment at random, season at delivery and for two women for recurrent malaria.